Simplex Trading’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$778K Sell
41,156
-7,070
-15% -$120K ﹤0.01% 2754
2025
Q4
$646K Buy
48,226
+7,061
+17% +$87.4K ﹤0.01% 3051
2025
Q3
$485K Sell
41,165
-46,786
-53% -$436K ﹤0.01% 3865
2025
Q2
$570K Buy
87,951
+40,095
+84% +$264K ﹤0.01% 3364
2025
Q1
$279K Buy
47,856
+37,628
+368% +$270K ﹤0.01% 3980
2024
Q4
$71K Buy
+10,228
New +$70.4K ﹤0.01% 5506
2024
Q3
Sell
-8,841
Closed -$61.5K 9153
2024
Q2
$63K Sell
8,841
-46,007
-84% -$402K ﹤0.01% 5843
2024
Q1
$515K Buy
54,848
+45,871
+511% +$262K ﹤0.01% 3836
2023
Q4
$32K Sell
8,977
-758
-8% -$2.28K ﹤0.01% 6504
2023
Q3
$30K Buy
+9,735
New +$40K ﹤0.01% 6256
2023
Q1
Sell
-1,374
Closed -$4.57K 9723
2022
Q4
$3K Sell
1,374
-33,023
-96% -$91.7K ﹤0.01% 8398
2022
Q3
$120K Buy
34,397
+33,661
+4,574% +$323K ﹤0.01% 5268
2022
Q2
$7K Buy
+736
New +$9.31K ﹤0.01% 8601
2022
Q1
Sell
-1,881
Closed -$32.6K 11029
2021
Q4
$38K Sell
1,881
-11,350
-86% -$362K ﹤0.01% 7598
2021
Q3
$680K Sell
13,231
-387
-3% -$16.7K ﹤0.01% 3656
2021
Q2
$704K Buy
+13,618
New +$715K ﹤0.01% 3644

Other funds holding DFTX

Simplex Trading's DFTX Position: Q1 2026 in Review

Simplex Trading reduced its Definium Therapeutics (DFTX) stake by 15% in Q1 2026, selling an estimated $120K and leaving 41,156 shares worth $778K. The position accounts for ﹤0.01% of the portfolio, ranked #2754.

Simplex Trading first reported a position in DFTX in Q2 2021 and has held it in 16 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Simplex Trading held 41,156 shares of Definium Therapeutics worth $778K as of Q1 2026.
  • Simplex Trading sold 7,070 Definium Therapeutics shares in Q1 2026, an estimated $120K.
  • Definium Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2754 holding.
  • Simplex Trading first reported a position in Definium Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.